These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC; Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173 [TBL] [Abstract][Full Text] [Related]
7. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation. Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336 [No Abstract] [Full Text] [Related]
8. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine. Parrotta EI; Scalise S; Scaramuzzino L; Cuda G Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081 [TBL] [Abstract][Full Text] [Related]
10. A practical guide to induced pluripotent stem cell research using patient samples. Santostefano KE; Hamazaki T; Biel NM; Jin S; Umezawa A; Terada N Lab Invest; 2015 Jan; 95(1):4-13. PubMed ID: 25089770 [TBL] [Abstract][Full Text] [Related]
11. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery. Corti S; Faravelli I; Cardano M; Conti L Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144 [TBL] [Abstract][Full Text] [Related]
12. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. Sayed N; Liu C; Wu JC J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349 [TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality? Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029 [TBL] [Abstract][Full Text] [Related]
14. Modeling different types of diabetes using human pluripotent stem cells. Abdelalim EM Cell Mol Life Sci; 2021 Mar; 78(6):2459-2483. PubMed ID: 33242105 [TBL] [Abstract][Full Text] [Related]
15. Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application. Takayama N; Eto K Cell Mol Life Sci; 2012 Oct; 69(20):3419-28. PubMed ID: 22527724 [TBL] [Abstract][Full Text] [Related]
16. Generation of human organs in pigs via interspecies blastocyst complementation. Wu J; Platero Luengo A; Gil MA; Suzuki K; Cuello C; Morales Valencia M; Parrilla I; Martinez CA; Nohalez A; Roca J; Martinez EA; Izpisua Belmonte JC Reprod Domest Anim; 2016 Oct; 51 Suppl 2():18-24. PubMed ID: 27762052 [TBL] [Abstract][Full Text] [Related]
17. Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes. Memon B; Abdelalim EM Stem Cells Transl Med; 2022 Jul; 11(7):704-714. PubMed ID: 35640144 [TBL] [Abstract][Full Text] [Related]
18. Generation of mice derived from induced pluripotent stem cells. Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420 [TBL] [Abstract][Full Text] [Related]